Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2000
The urokinase-type plasminogen activator system in resected non-small-cell lung cancer. Rotterdam Oncology Thoracic Study Group
M Salden, T A Splinter, H A Peters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1994
Plasminogen activator inhibitor-1 and prognosis in primary breast cancer
J A Foekens, M Schmitt, W L van Putten, et al.
The New England Journal of Medicine
|
August 13, 1981
Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy
M E Tripp, M L Katcher, H A Peters, et al.
International Journal of Cancer
|
February 15, 1978
A new aspect of the urinary excretion of tryptophan metabolites in patients with cancer of the bladder
F A Teulings, H A Peters, W C Hop, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
August 21, 2008
[Clinical reasoning and decision-making in practice. A man with hip pain and fever]
P R Tuinman, L C F de Nes, J L G Blaauwgeers, et al.
Cancer Research
|
November 1, 1989
Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols
J A Foekens, H Portengen, W L van Putten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Breast-conserving therapy: proteases as risk factors in relation to survival after local relapse
M E Meijer-van Gelder, M P Look, J Bolt-de Vries, et al.
Breast Cancer Research and Treatment
|
December 1, 2001
Clinical relevance of biologic factors in male breast cancer
M E Meijer-van Gelder, M P Look, J Bolt-de Vries, et al.
Cancer Research
|
April 1, 1995
Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer
J A Foekens, F Buessecker, H A Peters, et al.
International Journal of Cancer
|
June 17, 1998
Urokinase-type-plasminogen-activator (uPA) production by human breast (myo) fibroblasts in vitro: influence of transforming growth factor-beta(1) (TGF beta(1)) compared with factor(s) released by human epithelial-carcinoma cells
A M Sieuwerts, J G Klijn, S C Henzen-Logmand, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2000
The urokinase-type plasminogen activator system in resected non-small-cell lung cancer. Rotterdam Oncology Thoracic Study Group
M Salden, T A Splinter, H A Peters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1994
Plasminogen activator inhibitor-1 and prognosis in primary breast cancer
J A Foekens, M Schmitt, W L van Putten, et al.
The New England Journal of Medicine
|
August 13, 1981
Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy
M E Tripp, M L Katcher, H A Peters, et al.
International Journal of Cancer
|
February 15, 1978
A new aspect of the urinary excretion of tryptophan metabolites in patients with cancer of the bladder
F A Teulings, H A Peters, W C Hop, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
August 21, 2008
[Clinical reasoning and decision-making in practice. A man with hip pain and fever]
P R Tuinman, L C F de Nes, J L G Blaauwgeers, et al.
Cancer Research
|
November 1, 1989
Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols
J A Foekens, H Portengen, W L van Putten, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Breast-conserving therapy: proteases as risk factors in relation to survival after local relapse
M E Meijer-van Gelder, M P Look, J Bolt-de Vries, et al.
Breast Cancer Research and Treatment
|
December 1, 2001
Clinical relevance of biologic factors in male breast cancer
M E Meijer-van Gelder, M P Look, J Bolt-de Vries, et al.
Cancer Research
|
April 1, 1995
Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer
J A Foekens, F Buessecker, H A Peters, et al.
International Journal of Cancer
|
June 17, 1998
Urokinase-type-plasminogen-activator (uPA) production by human breast (myo) fibroblasts in vitro: influence of transforming growth factor-beta(1) (TGF beta(1)) compared with factor(s) released by human epithelial-carcinoma cells
A M Sieuwerts, J G Klijn, S C Henzen-Logmand, et al.
Page
of 7